Françoise Brignole-Baudouin Selected Research

Omega-6 Fatty Acids (Omega 6 Fatty Acids)

11/2011

A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Françoise Brignole-Baudouin Research Topics

Disease

15	Inflammation (Inflammations) 02/2020 - 03/2004
14	Dry Eye Syndromes (Dry Eye Syndrome) 05/2020 - 05/2010
9	Glaucoma 02/2022 - 07/2005
4	Uveitis 01/2022 - 10/2007
2	Wounds and Injuries (Trauma) 11/2012 - 01/2012
1	Edema (Dropsy) 03/2022
1	Gliosis 03/2022
1	Epiretinal Membrane (Epiretinal Membranes) 03/2022
1	Infections 03/2022
1	Toxoplasmosis 03/2022
1	Retinitis 03/2022
1	Chorioretinitis 03/2022
1	Ulcer 12/2020
1	Eye Diseases (Eye Disease) 11/2020
1	Mucopolysaccharidosis I (Hurler Syndrome) 10/2020
1	Mydriasis 04/2020
1	Phototoxic Dermatitis (Phototoxicity) 10/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2017
1	Craniocerebral Trauma (Head Injury) 12/2016
1	Ocular Hypertension (Glaucoma, Suspect) 09/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Photophobia (Light Sensitivity) 05/2015
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2015
1	Herpes Zoster 06/2011
1	Metaplasia 07/2010
1	Pruritus (Itching) 05/2010
1	Foreign Bodies (Foreign Body) 05/2010
1	Blepharitis 05/2010
1	Long Term Adverse Effects 08/2009

Drug/Important Bio-Agent (IBA)

8	Ophthalmic Solutions (Eye Drops)IBA 04/2020 - 03/2004
7	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 02/2020 - 01/2012
7	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 07/2005
4	Latanoprost (Xalatan)FDA Link 02/2022 - 01/2008
3	ChemokinesIBA 01/2022 - 01/2008
3	HCEIBA 05/2020 - 06/2011
2	Retinaldehyde (Retinal)IBA 03/2022 - 09/2015
2	Fibronectins (Fibronectin)IBA 03/2022 - 02/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 01/2022
2	LipidsIBA 05/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	AntioxidantsIBA 10/2018 - 12/2016
2	EmulsionsIBA 11/2012 - 08/2009
2	ProstaglandinsIBA 05/2010 - 07/2005
2	Fluorescein (Funduscein)FDA LinkGeneric 05/2010 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 11/2006
2	EndotoxinsIBA 06/2008 - 01/2008
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2008 - 07/2005
2	Antiglaucoma AgentsIBA 01/2008 - 03/2004
2	Chemokine ReceptorsIBA 01/2008 - 01/2008
2	LipopolysaccharidesIBA 07/2007 - 11/2006
1	Messenger RNA (mRNA)IBA 03/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2022
1	Transforming Growth Factor beta2IBA 02/2022
1	rho-Associated KinasesIBA 02/2022
1	CytokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 12/2020
1	Detergents (Detergent)IBA 11/2020
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 04/2020
1	Tropicamide FDA LinkGeneric 04/2020
1	Quaternary Ammonium CompoundsIBA 02/2020
1	Glutathione (Reduced Glutathione)IBA 10/2018
1	EnkephalinsIBA 04/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2018
1	HLA-DR alpha-ChainsIBA 01/2018
1	NeuroglobinIBA 06/2017
1	Proteins (Proteins, Gene)FDA Link 06/2017
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 06/2017
1	Arginine (L-Arginine)FDA Link 12/2016
1	Neuroprotective AgentsIBA 09/2015
1	dicarboxydine (DCD)IBA 05/2015
1	Phosphates (Orthophosphate)IBA 11/2012
1	2-aminoethylmethacrylate (AEM)IBA 01/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 11/2011
1	AntigensIBA 11/2011
1	Zonula Occludens-1 ProteinIBA 06/2011
1	OccludinIBA 06/2011
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2011
1	Ammonium CompoundsIBA 07/2010
1	tafluprostIBA 05/2010
1	AntibodiesIBA 02/2010
1	Chemokine CCL5IBA 01/2008
1	Travoprost (Travatan)FDA Link 01/2008
1	Histocompatibility Antigens Class IIIBA 01/2008
1	Bimatoprost (Lumigan)FDA Link 01/2008

Therapy/Procedure

3	Therapeutics 03/2022 - 01/2012
2	Contact Lenses 03/2022 - 06/2014
2	Slit Lamp 05/2015 - 12/2007
1	Duration of Therapy 12/2020
1	Corneal Transplantation (Keratoplasty) 10/2020
1	Hematopoietic Stem Cell Transplantation 10/2020
1	Cautery 09/2015